JOP20250164A1 - مركبات تعديل مستقبلات الدوبامين d3/d2 - Google Patents

مركبات تعديل مستقبلات الدوبامين d3/d2

Info

Publication number
JOP20250164A1
JOP20250164A1 JOJO/P/2025/0164A JOP20250164A JOP20250164A1 JO P20250164 A1 JOP20250164 A1 JO P20250164A1 JO P20250164 A JOP20250164 A JO P20250164A JO P20250164 A1 JOP20250164 A1 JO P20250164A1
Authority
JO
Jordan
Prior art keywords
dopamine
receptor modulators
formula
present
compounds
Prior art date
Application number
JOJO/P/2025/0164A
Other languages
Arabic (ar)
English (en)
Inventor
Borza István
MENCZINGER Bálint
ELES János
BODNÁRNÉ DÉAK Szilvia
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of JOP20250164A1 publication Critical patent/JOP20250164A1/ar

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JOJO/P/2025/0164A 2023-01-11 2025-07-10 مركبات تعديل مستقبلات الدوبامين d3/d2 JOP20250164A1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363479530P 2023-01-11 2023-01-11
PCT/IB2024/000026 WO2024150068A2 (en) 2023-01-11 2024-01-10 Dopamine d3/d2 receptor modulating compounds

Publications (1)

Publication Number Publication Date
JOP20250164A1 true JOP20250164A1 (ar) 2025-07-10

Family

ID=89573273

Family Applications (1)

Application Number Title Priority Date Filing Date
JOJO/P/2025/0164A JOP20250164A1 (ar) 2023-01-11 2025-07-10 مركبات تعديل مستقبلات الدوبامين d3/d2

Country Status (16)

Country Link
US (2) US12168007B1 (https=)
EP (1) EP4400495A1 (https=)
JP (2) JP7686096B2 (https=)
KR (2) KR102921799B1 (https=)
CN (1) CN120569367A (https=)
AR (1) AR131577A1 (https=)
AU (1) AU2024208533A1 (https=)
CL (1) CL2025002035A1 (https=)
CO (1) CO2025010725A2 (https=)
GE (1) GEAP202516807A (https=)
IL (1) IL321654A (https=)
JO (1) JOP20250164A1 (https=)
MX (1) MX2025008101A (https=)
PE (1) PE20260287A1 (https=)
TW (1) TW202432139A (https=)
WO (1) WO2024150068A2 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
EP1870405A1 (en) 2006-06-22 2007-12-26 Bioprojet Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
CA2937222C (en) 2009-06-25 2019-06-04 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds
WO2020156312A1 (zh) 2019-01-30 2020-08-06 江苏豪森药业集团有限公司 一种多环类衍生物调节剂、其制备方法和应用
MX2022004473A (es) 2019-10-29 2022-05-06 Shanghai Hansoh Biomedical Co Ltd Modificador de un derivado de anillo de cuatro miembros, metodo de preparacion y aplicacion del mismo.
US12459931B2 (en) * 2019-11-05 2025-11-04 Shanghai Hansoh Biomedical Co., Ltd. Benzothiophene derivative regulator, preparation method therefor and use thereof

Also Published As

Publication number Publication date
PE20260287A1 (es) 2026-02-10
TW202432139A (zh) 2024-08-16
JP7686096B2 (ja) 2025-05-30
JP2024098972A (ja) 2024-07-24
EP4400495A1 (en) 2024-07-17
CN120569367A (zh) 2025-08-29
JP2025122072A (ja) 2025-08-20
IL321654A (en) 2025-08-01
KR20240112213A (ko) 2024-07-18
AU2024208533A1 (en) 2025-07-10
KR102921799B1 (ko) 2026-02-04
WO2024150068A2 (en) 2024-07-18
KR20260019592A (ko) 2026-02-10
AR131577A1 (es) 2025-04-09
WO2024150068A3 (en) 2024-08-22
MX2025008101A (es) 2025-08-01
GEAP202516807A (en) 2025-08-25
CL2025002035A1 (es) 2025-10-03
US20250049786A1 (en) 2025-02-13
CO2025010725A2 (es) 2025-08-29
US12168007B1 (en) 2024-12-17

Similar Documents

Publication Publication Date Title
JOP20230316B1 (ar) N-(هيدروكسي ألكيل أريل (غير متجانس)) تترا هيدروفيوران كربوكساميدات كمعدلات لقنوات الصوديوم
MX2023007192A (es) Inhibidores de prmt5.
JOP20230113A1 (ar) مشتقات ثلاثية الكربوكساميد كمثبطات prmt5
JOP20220271A1 (ar) مركبات دايازينو بيريميدين كمثبطات لـ her2
CR20220371A (es) Agonistas heterocíclicos de glp-1
BR112013009365A2 (pt) uso de um composto da seguinte fórmula (i) ou um sal farmaceuticamente aceitável solvato ou composição do mesmo, composto da formula (i), composição farmaceutica, metodo para o tratamento de uma condição ou desordem em que bloqueadores de canal ttx-s estao envolvidos em um animal, incluindo um humano e processo para preparar uma composiçao farmaceutica.
JOP20240165A1 (ar) مشتقات بيبريدينيل سبيرو سيكليك كمثبطات عامل مكمل b واستخداماتها
EA201170705A1 (ru) Арилметилбензохиназолиноны в качестве позитивных аллостерических модуляторов рецептора м1
JOP20230128A1 (ar) مركبات صيدلانية
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
ECSP11011561A (es) Derivados aminobutíricos sustituidos como inhibidores de neprilisina
EA201071040A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40
MY208400A (en) Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (ror) and pharmaceutical uses thereof
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
JOP20250025A1 (ar) صور بلورية وأملاح من ناهض مستقبل مسكاريني
AR082968A1 (es) Inhibidores biciclicos de notum pectinacetilesterasa y una composicion farmaceutica en base al compuesto
CL2007002899A1 (es) Compuestos derivados de azaciclilaminas n-sustituidas, inhibidores del receptor de histamina 3; proceso de preparacion; composicion farmaceutica que comprende los compuestos, y usopara el tratamiento de trastornos cognitivos, esquizofre nia y enfermedad de alzheimer entre otros.
MA38854B1 (fr) Dérivés amides utilisés en tant qu'antagonistes des récepteurs de l'acide lysophosphatidique
UY40235A (es) Compuestos de heteroarilo para el tratamiento del dolor
MA49127B1 (fr) Dérivés d'indole n-substitués
EA202192900A1 (ru) Модуляторы пути интегрированной реакции на стресс
MA34094B1 (fr) Dérivés de 3-(hétéroarylamino)-1,2,3,4-tétrahydro-9h-carbazole et leur utilisation comme modulateurs du récepteur de la prostaglandine d2
MA41337A (fr) Dérivés de l'hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3
DOP2019000076A (es) DERIVADOS DE CROMANO, ISOCROMANO Y DIHIDROISOBENZOFURANOS COMO MODULADORES ALOSTÉRICOS NEGATIVOS DE mGluR2, COMPOSICIONES Y SU USO
EP4635494A3 (en) AMIDO HETERO-ROMATIC COMPOUNDS